Hamilton Point Investment Advisors, LLC Gilead Sciences, Inc. Transaction History

Hamilton Point Investment Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Jul 18, 2018	SELL	$64.88 - $75.68 $1.64 Million - $1.91 Million	-25,299 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$72.84 - $88.8 $220,778 - $269,152	3,031 Added 13.61%	25,299 $1.91 Million
Q4 2017 Feb 12, 2018	SELL	$71.15 - $83.52 $57,133 - $67,066	-803 Reduced 3.48%	22,268 $1.6 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $3,605 - $4,273	50 Added 0.22%	23,071 $1.87 Million
Q2 2017 Aug 14, 2017	BUY	N/A	23,021	23,021 $1.63 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Hamilton Point Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Hamilton Point Investment Advisors, LLC with notifications on news.